Impact of eHealth Education to Reduce Anemia Among School-going Adolescent Girls in Rural Bangladesh
- Disease/Condition
- Anemia
- Drug/Device/Intervention
- eHealth education
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Hiroshima University
- Location
- Chandpur, Bangladesh
- Phase
- N/A
- Start date
- May 22, 2022
- End date
- Sep 30, 2023
- Enrollment
- 138 participants
Impact of eHealth education to change the anemia level among school-going adolescent girls in rural areas of Bangladesh
Adolescent girls are the highly vulnerable group to develop anemia due to reproductive
 immaturities, poor personal hygiene, lack of nutritional intake, and lack of health education
 in the rural area of Bangladesh. Rapid advantage of technology, eHealth is the promising tool
 to overcome the barriers and provide appropriate health guidelines in distant rural
 communities by developing knowledge, attitude, and practice to reduce anemia and mitigate
 risk among the school-going adolescent girls. This research aims (1) To evaluate eHealth
 education's impact on reducing anemia among adolescent girls in rural Bangladesh. (2) To
 assess the effect of eHealth education to change the knowledge, attitude, and practice among
 adolescent girls regarding anemia. A Randomized Control Trial study will be conducted from
 May 22, 2022, to January 21, 2023, in the two schools at the Chandpur district, Bangladesh.
 During the 8th months' intervention, will be provided eHealth education by the trained
 community health worker. The participant will be allocated who will be diagnosed as anemic
 through the blood hemoglobin screening. The sample size was calculated, and the total sample
 is 138. In this study, one school will be considered an intervention group and another school
 control group through the simple coin toss randomization technique. Then random sampling
 technique will be used to select study participants.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05185661
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05185661 through Pure Global AI's free database. This phase not specified trial is sponsored by Hiroshima University and is currently Active, not recruiting. The study focuses on Anemia. Target enrollment is 138 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.